ChatGPT for Histotechnologists: 35 Prompts to Write Tissue Processing Logs, QC Reports, and Training SOPs Faster

Write a formal tissue processing deviation report for a specimen with inadequate fixation. Use de-identified placeholders only. Accession: [ACCESSION_PLACEHOLDER]. Specimen type: [SPECIMEN_TYPE] (e.g., colon resection, breast core biopsy, prostate needle biopsy). Technician: [TECH_NAME], [CREDENTIAL]. Supervisor: [SUPERVISOR_NAME_PLACEHOLDER].

Deviation description: [DEVIATION_DESCRIPTION] (e.g., delayed formalin entry — specimen received in [FIXATIVE_TYPE] at [RECEIVED_TIME] but fixative addition delayed until [FIXATION_START_TIME], resulting in estimated pre-fixation interval of [INTERVAL_HOURS] hours; per College of American Pathologists [CAP] guidelines, minimum fixation time in 10% neutral buffered formalin for [SPECIMEN_TYPE] is [MIN_FIXATION_TIME] hours with a maximum cold ischemia time of [MAX_COLD_ISCHEMIA] hours for receptor testing).

Impact on tissue quality: [IMPACT_DESCRIPTION] (e.g., potential inadequate antigen preservation for IHC receptor testing — ER/PR/HER2 on breast core; poor nuclear detail on colon sections; autolysis artifact present on H&E).

Corrective action: [CORRECTIVE_ACTION] (e.g., pathologist Dr. [PATHOLOGIST_NAME] notified — requesting notation on final report regarding fixation deviation; tissue re-fixation attempted per [PROTOCOL]; specimen retained per department protocol; IHC testing on hold pending pathologist decision).

Root cause: [ROOT_CAUSE_PLACEHOLDER]. Preventive measure: [PREVENTIVE_MEASURE]. Write approximately 150–175 words in formal deviation report format consistent with CAP accreditation requirements.

Write a tissue processing deviation report for an over-processed specimen. Technician: [TECH_NAME], [CREDENTIAL]. Accession: [ACCESSION_PLACEHOLDER]. Specimen type: [SPECIMEN_TYPE]. Processing protocol used: [PROTOCOL_NAME] (e.g., routine overnight processing, extended tissue processing cycle). Deviation: specimen processed for [ACTUAL_TIME] hours using [REAGENTS_USED] — standard protocol for this specimen type calls for [STANDARD_PROTOCOL] hours. Over-processing identified at: [IDENTIFICATION_POINT] (e.g., embedding station, at sectioning when brittle tissue noted). Tissue appearance: [TISSUE_APPEARANCE] (e.g., brittle, chalky white on cut surface, extremely fragile on sectioning — ribbon tears, sections lifting from water bath at [TEMP]°C). Impact: potential compromise of tissue architecture and staining quality, particularly for [SPECIFIC_STAINS_PLACEHOLDER] (e.g., IHC, mucin special stains). Pathologist Dr. [PATHOLOGIST_NAME] notified at [NOTIFICATION_TIME]. Action taken: [ACTION_PLACEHOLDER]. Root cause: [ROOT_CAUSE_PLACEHOLDER]. Write approximately 130–155 words in deviation report format.

Write a cassette identification discrepancy report. Technician: [TECH_NAME], [CREDENTIAL]. Discovery time: [DISCOVERY_TIME] at [DISCOVERY_LOCATION] (e.g., at embedding station, at microtome, at labeling station). Accession(s) involved: [ACCESSION_PLACEHOLDER_1] and [ACCESSION_PLACEHOLDER_2] (if cross-case discrepancy). Discrepancy type: [DISCREPANCY_TYPE] (e.g., cassette label faded — accession number illegible; cassette marking matches neither the gross description log entry nor the requisition; cassette found in incorrect processing basket — accession [X] cassette found in case [Y] batch; duplicate cassette number identified within the same case).

Immediate action: [IMMEDIATE_ACTION] (e.g., processing halted on affected cassettes; supervisor [SUPERVISOR_NAME] notified immediately; requisition cross-reference performed; pathologist [PATHOLOGIST_NAME] notified). Gross description review performed: [GROSS_REVIEW_STATUS — discrepancy resolved / cannot be resolved]. Final cassette status: [CASSETTE_STATUS_PLACEHOLDER]. Quality event report filed: [QE_REPORT_PLACEHOLDER]. Write approximately 120–145 words, patient safety quality event report format consistent with CAP Q-Probes standards.

Write a deviation report for a specimen received in an improper or insufficient fixative. Accession: [ACCESSION_PLACEHOLDER]. Specimen type: [SPECIMEN_TYPE]. Required fixative per protocol: [REQUIRED_FIXATIVE] (e.g., 10% neutral buffered formalin; B-5 fixative for lymph node and bone marrow; Michel's transport medium for direct immunofluorescence; glutaraldehyde for electron microscopy). Fixative received: [ACTUAL_FIXATIVE] (e.g., saline — no formalin added; no fixative — dry specimen; Bouin's fixative — requested but contraindicated for [TESTS_ORDERED_PLACEHOLDER] due to [REASON]).

Time of receipt: [RECEIPT_TIME]. Volume of fixative: [VOLUME_STATUS] (e.g., insufficient volume — tissue not fully submerged; fixative-to-tissue ratio < 10:1 for formalin-fixed specimens per CAP/ASCO guidelines). Immediate action: [IMMEDIATE_ACTION_PLACEHOLDER]. Pathologist Dr. [PATHOLOGIST_NAME] notified at [NOTIFICATION_TIME]. Impact on downstream testing: [IMPACT_PLACEHOLDER]. Root cause: [ROOT_CAUSE_PLACEHOLDER]. Write approximately 130–150 words in formal deviation report format.

Write a documentation note for an embedding orientation deviation identified at the microtome. Technician: [TECH_NAME], [CREDENTIAL]. Accession: [ACCESSION_PLACEHOLDER]. Specimen type: [SPECIMEN_TYPE]. Embedding performed by: [EMBEDDER_NAME_PLACEHOLDER]. Deviation identified at: [IDENTIFICATION_POINT] (e.g., sectioning station, at QC review of slide). Orientation error description: [ERROR_DESCRIPTION] (e.g., biopsy fragment embedded on edge rather than flat — transverse cross-section not obtained; skin punch biopsy embedded without en face orientation — layers not visible on section; colon biopsy fragments embedded without mucosal surface tangential — villi not assessable). Impact: [IMPACT] (e.g., sections do not represent tissue architecture required for diagnostic evaluation; deeper levels required; re-embedding required — cassette re-processed). Action taken: [ACTION_PLACEHOLDER] (e.g., block re-melted and re-embedded per supervisor approval; deeper levels cut; pathologist notified). Write approximately 110–130 words.

Write a documentation note for cryostat contamination identified during or after frozen section processing. Technician: [TECH_NAME], [CREDENTIAL]. Accession: [ACCESSION_PLACEHOLDER]. Incident date/time: [INCIDENT_DATE] at [INCIDENT_TIME]. Contamination type: [CONTAMINATION_TYPE] (e.g., floater tissue present on frozen section slide — foreign tissue fragment not consistent with submitted specimen; cryostat chuck or stage contamination — tissue debris from prior case present on cutting surface; cross-contamination between consecutive cases). Contaminating tissue identified as: [CONTAMINANT_DESCRIPTION_PLACEHOLDER] (consistent with [TISSUE_TYPE_PLACEHOLDER] — not from current case). Discovery point: [DISCOVERY_POINT] (e.g., identified by pathologist Dr. [PATHOLOGIST_NAME] at microscopic review; identified by technician during slide preparation). Immediate action: [ACTION] (e.g., cryostat decontamination procedure initiated per SOP; pathologist notified; case placed on hold; additional sections from deeper level requested). Cryostat decon completed by: [TECH_PLACEHOLDER] at [COMPLETION_TIME]. QI event filed. Write approximately 130–150 words.

Write a tissue processing documentation note for a bone or calcified tissue specimen requiring decalcification. Accession: [ACCESSION_PLACEHOLDER]. Specimen type: [SPECIMEN_TYPE] (e.g., bone core biopsy, rib segment, iliac crest biopsy, calcified lung nodule). Technician: [TECH_NAME], [CREDENTIAL]. Fixation: specimen received in [FIXATIVE] on [RECEIPT_DATE] at [RECEIPT_TIME]. Fixation time prior to decalcification initiation: [FIXATION_TIME] hours. Decalcification method: [DECAL_METHOD] (e.g., strong acid — 5% nitric acid; weak acid — formic acid-formalin [Gooding-Stewart solution]; chelation — EDTA [ethylenediaminetetraacetic acid, 0.5 M pH 7.0 — gentler, preserves antigenicity for IHC]). Decalcification start time: [DECAL_START_TIME]. End-point determination method: [ENDPOINT_METHOD] (e.g., bend test, radiograph, needle test — per [SOP_NAME]). Endpoint confirmed: [ENDPOINT_TIME]. Total decalcification time: [TOTAL_TIME]. Proceeding to standard processing: [PROCESSING_START_TIME]. Rationale for method selected (especially if IHC ordered): [RATIONALE_PLACEHOLDER]. Write approximately 120–140 words in specimen processing log format.

Write a formal QC failure report for a special stain control failure. QC date: [QC_DATE]. Stain: [STAIN_NAME] (e.g., Periodic Acid-Schiff [PAS], Gomori Methenamine Silver [GMS], Masson's Trichrome, Alcian Blue pH 2.5, Giemsa, Ziehl-Neelsen acid-fast, Warthin-Starry). Control type: [CONTROL_TYPE] (e.g., positive tissue control, negative tissue control, reagent blank). Expected control result: [EXPECTED_RESULT] (e.g., PAS positive control — glycogen granules magenta/purple in liver; basement membranes magenta; GMS positive — fungal organisms black against green counterstain). Observed control result: [OBSERVED_RESULT] (e.g., no magenta staining in positive control; faint background staining only; overstained — non-specific black precipitate throughout tissue).

Failure mode identified: [FAILURE_MODE] (e.g., PAS — periodic acid oxidation time insufficient [used [TIME] min vs. SOP-required [TIME] min]; GMS — methenamine silver incubation temperature incorrect [[ACTUAL_TEMP]°C vs. required [REQUIRED_TEMP]°C]; reagent expired on [EXPIRY_DATE]).

Immediate action: patient slides withheld. Corrective action: [CORRECTIVE_ACTION_PLACEHOLDER] (e.g., stain repeated with corrected parameters; reagent replaced). Repeat QC result: [REPEAT_QC_RESULT_PLACEHOLDER]. Patient slides released: [RELEASE_STATUS]. Supervisor: [SUPERVISOR_PLACEHOLDER]. Lab director review: [DIRECTOR_REVIEW_PLACEHOLDER]. Write approximately 150–175 words in CAP-compliant QC failure report format.

Write an IHC troubleshooting log entry for a staining failure or suboptimal IHC result. Accession context: [ACCESSION_CONTEXT_PLACEHOLDER — no real accession numbers]. Antibody: [ANTIBODY_NAME] (e.g., ER [estrogen receptor], Ki-67, CK5/6, CD20, p53, TTF-1, PD-L1 22C3). Platform: [PLATFORM] (e.g., Leica BOND-III, Ventana BenchMark ULTRA, Dako Autostainer). Run date: [RUN_DATE]. Retrieval method: [RETRIEVAL_METHOD] (e.g., CC1 [Cell Conditioning 1] high-pH EDTA at 95°C for [TIME] min; proteinase K enzymatic retrieval). Primary antibody dilution/concentration: [DILUTION_PLACEHOLDER]. Incubation time/temperature: [INCUBATION_PARAMETERS].

Failure description: [FAILURE_DESCRIPTION] (e.g., no DAB staining in positive control — complete loss of signal; high non-specific background — brown precipitate throughout; weak signal on positive control — expression intensity insufficient for scoring; staining limited to edge artifact — center of section unstained).

Troubleshooting steps taken: [TROUBLESHOOTING_STEPS] (e.g., antibody lot verified and in-date, retrieval time extended, antibody concentration titrated, new antibody lot tested). Resolution: [RESOLUTION_PLACEHOLDER]. Patient case status: on hold pending resolution. Pathologist Dr. [PATHOLOGIST_NAME] notified at [NOTIFICATION_TIME]. Write approximately 150–170 words.

Write a QC log entry documenting an H&E (hematoxylin and eosin) staining quality issue. Staining batch date: [BATCH_DATE]. Automated stainer: [STAINER_MODEL_PLACEHOLDER]. Batch size: [BATCH_SIZE] slides. QC reviewer: [TECH_NAME], [CREDENTIAL].

Issue identified: [ISSUE_DESCRIPTION] (choose one for the prompt — e.g., pale/washed-out hematoxylin — nuclei poorly defined, insufficient basophilia; overstained hematoxylin — nuclei too dark, cytoplasmic detail obscured; pale eosin — cytoplasm and connective tissue insufficiently stained; precipitate artifact — hematoxylin precipitate deposits on sections; section lifting — sections detaching from slides during staining).

Root cause investigation: [ROOT_CAUSE] (e.g., hematoxylin solution depleted — ripening time exceeded [X] weeks; eosin alcohol concentration diluted to [X]% vs. required [X]%; acid differentiation step timing error; water bath temperature deviation at [BATH_STEP]).

Corrective action: [CORRECTIVE_ACTION_PLACEHOLDER]. Affected slides restained: [RESTAIN_STATUS]. QC re-review result: [QC_RECHECK_RESULT]. Pathologist Dr. [PATHOLOGIST_NAME] notified (if patient slides affected): [NOTIFICATION_STATUS]. Write approximately 130–155 words.

Write a corrective action log entry for a section quality problem identified at the microtome. Technician: [TECH_NAME], [CREDENTIAL]. Date: [DATE]. Accession: [ACCESSION_PLACEHOLDER]. Specimen type: [SPECIMEN_TYPE].

Section quality issue: [ISSUE_TYPE] (select one for the prompt):
- Chatter/chattering artifact — parallel lines/ridges across the section, appearing as alternating thick and thin bands, caused by [CAUSE_PLACEHOLDER] (e.g., dull microtome blade, loose block clamp, specimen too hard/brittle, vibration from nearby equipment).
- Compression artifact — tissue compressed in the direction of cutting, creating a wrinkled or accordion-like appearance, caused by [CAUSE_PLACEHOLDER] (e.g., dull blade, section cut too thick, wax too soft for room temperature).
- Holes/tears in sections — tissue fragments tearing or falling out during sectioning, caused by [CAUSE_PLACEHOLDER] (e.g., air pockets in block, incomplete paraffin infiltration, over-processing).
- Section thickness inconsistency — sections vary from [MIN_THICKNESS] to [MAX_THICKNESS] μm when [TARGET_THICKNESS] μm required, caused by [CAUSE_PLACEHOLDER].

Corrective action taken: [ACTION_PLACEHOLDER] (e.g., blade replaced, block temperature adjusted, re-embedding performed, trimming protocol revised). Outcome: [OUTCOME_PLACEHOLDER]. Write approximately 120–140 words in QC corrective action log format.

Write a reagent failure and replacement documentation entry for the histology lab QC records. QC date: [QC_DATE]. Reagent: [REAGENT_NAME] (e.g., Harris hematoxylin, Eosin Y 0.5% alcoholic solution, periodic acid [PAS protocol], xylene substitute clearing agent, paraffin [MELTING_POINT]°C, antigen retrieval buffer pH 6.0 citrate). Lot number: [LOT_NUMBER_PLACEHOLDER]. Expiration date: [EXP_DATE_PLACEHOLDER]. Failure mode: [FAILURE_MODE] (e.g., reagent expired and QC failure confirmed on [QC_DATE]; reagent contaminated — precipitate visible; reagent improperly stored — [STORAGE_VIOLATION]; incoming reagent QC failure on control run [DATE]).

Immediate action: all patient batches using this reagent lot on hold. Affected stain runs: [AFFECTED_RUNS_PLACEHOLDER]. Replacement lot: [NEW_LOT_PLACEHOLDER]. New lot QC performed: [NEW_LOT_QC_DATE]. New lot QC result: [NEW_LOT_QC_RESULT]. Patient work released: [RELEASE_DATE_PLACEHOLDER]. Supervisor: [SUPERVISOR_PLACEHOLDER]. Write approximately 110–130 words in reagent log format consistent with CLIA requirements.

Write an instrument maintenance log entry for an automated tissue processor. Instrument: [INSTRUMENT_NAME_PLACEHOLDER] (e.g., Leica ASP300S, Sakura Tissue-Tek VIP 6 AI, Thermo Scientific STP 120). Maintenance type: [MAINTENANCE_TYPE] (e.g., daily reagent level check and top-off, weekly reagent change, monthly preventive maintenance, unscheduled maintenance — [ISSUE_DESCRIPTION]). Date/time: [MAINTENANCE_DATE] at [MAINTENANCE_TIME]. Performed by: [TECH_NAME], [CREDENTIAL]. Reagents changed or topped off: [REAGENT_STATUS] (e.g., Formalin station 1 — topped off to [VOLUME]; ethanol 70% stations 2–3 — replaced; ethanol 95% stations 4–5 — replaced; absolute ethanol stations 6–8 — replaced; xylene/xylene substitute stations 9–11 — replaced; paraffin reservoir — fresh paraffin added, temperature confirmed at [TEMP]°C). Function check post-maintenance: [FUNCTION_CHECK] (e.g., instrument run test cycle completed without error; sensor calibration verified). Next scheduled maintenance: [NEXT_MAINTENANCE_DATE]. Supervisor sign-off: [SUPERVISOR_PLACEHOLDER]. Write approximately 120–140 words in instrument maintenance log format.

Write a proficiency testing failure response documentation entry. PT program: [PT_PROGRAM] (e.g., CAP Surveys — Histology [HIS], Immunohistochemistry [IHC], Special Stains [SS]; CLIA-approved PT provider). PT event: [PT_EVENT_PLACEHOLDER]. Test: [TEST_NAME] (e.g., H&E morphology evaluation, GMS fungal stain PT, Ki-67 IHC PT, PAS PT). Graded result: [PT_RESULT] (unsuccessful — [SCORE]% correct; required threshold: [REQUIRED_THRESHOLD]%). Failure mode (if identifiable from PT feedback): [FAILURE_MODE_PLACEHOLDER].

Root cause investigation: [ROOT_CAUSE_INVESTIGATION] (e.g., staining protocol review completed — identified deviation in [PROTOCOL_STEP]; antibody concentration outside validated range; comparison with prior successful PT events suggests [ISSUE]).

Corrective action plan: [CORRECTIVE_ACTION_PLAN] (e.g., re-validation of [STAIN/ANTIBODY] protocol on [DATE]; staff retraining on [PROTOCOL_STEP] completed by [DATE]; repeat PT ordered — educational only). Follow-up PT result: [FOLLOW_UP_RESULT_PLACEHOLDER]. Lab director attestation: [DIRECTOR_PLACEHOLDER]. Required response timeline: within [DAYS] days of PT failure notification per CLIA regulations. Write approximately 150–175 words in formal PT failure response format.

Write a frozen section procedure SOP suitable for new employee orientation in the histopathology department. Include: (1) Purpose and scope — frozen section diagnosis provides intraoperative rapid diagnosis; time-sensitive; requires precise technique to preserve tissue architecture, (2) Materials and equipment — cryostat (model: [CRYOSTAT_MODEL_PLACEHOLDER]), OCT embedding medium, cryomolds, glass slides, hematoxylin (rapid), eosin (rapid), mounting medium, personal protective equipment, (3) Pre-procedure cryostat preparation — temperature verification ([TEMP]°C), anti-roll plate position, blade replacement per SOP, (4) Specimen receipt — received from OR via [TRANSPORT_METHOD]; two-patient identifier verification; gross examination by pathologist Dr. [PATHOLOGIST_PLACEHOLDER], (5) Tissue embedding in OCT — orientation per pathologist instruction, snap-freezing technique, (6) Sectioning — target section thickness [THICKNESS] μm; anti-roll plate technique for flat sections; mounting on pre-labeled slides, (7) Rapid H&E staining — [STAIN_PROTOCOL_PLACEHOLDER], (8) Slide delivery to pathologist — target turnaround: diagnosis within [TAT_STANDARD_PLACEHOLDER] minutes of specimen receipt, (9) Residual tissue handling — post-frozen section tissue submitted for permanent processing, (10) Cryostat decontamination after each case. Write approximately 375–425 words with numbered steps and headers.

Write an H&E staining procedure SOP for an automated stainer. Instrument: [STAINER_MODEL_PLACEHOLDER]. Protocol name: [PROTOCOL_NAME_PLACEHOLDER]. Purpose: produce diagnostic quality H&E sections with well-differentiated nuclear basophilia and cytoplasmic/stromal eosinophilia for pathologist review. Include: (1) QC requirements — run positive tissue control at start of each day/batch; review control slide before releasing patient slides, (2) Reagent list and sequence — Harris hematoxylin [CONCENTRATION/DWELL_TIME], bluing reagent, Scott's tap water or ammonia water, Eosin Y [CONCENTRATION/DWELL_TIME], graded alcohols (70%, 95%, 100% x2), xylene/xylene substitute x2, mounting medium, (3) Section preparation — [BAKING_PROTOCOL] (e.g., 60°C oven for [TIME] prior to staining), (4) Critical QC checkpoints — hematoxylin staining intensity (nuclear blue/purple, no precipitate), acid differentiation time ([TIME_PLACEHOLDER] seconds — over-differentiation will wash out nuclei), eosin intensity (cytoplasm pink/red, collagen deep pink), (5) Troubleshooting table — 4 common issues with causes and corrections, (6) Documentation requirements per CLIA/CAP. Write approximately 375–425 words with structured headers.

Write a structured 30-day orientation checklist for a new histotechnician or histotechnologist. Include milestones by week:

Week 1 — Orientation and Safety: lab tour, safety training (PPE, chemical hygiene, sharps, formalin exposure protocol), HIPAA and specimen confidentiality, LIS (Laboratory Information System) access and accession review, departmental SOPs — location and structure.

Week 2 — Processing and Embedding: tissue processor loading/unloading protocol, cassette labeling and identification verification, paraffin embedding technique (block orientation, cooling, quality check), sectioning basics on microtome — blade installation, section mounting, water bath technique.

Week 3 — Staining and Slide Preparation: routine H&E automated staining — loading, QC review, coverslipping; special stain protocol introduction ([STAINS_PLACEHOLDER] — review SOP, perform supervised run); IHC platform orientation — reagent loading, run initiation, control review.

Week 4 — QC, Documentation, and Independence: QC log completion, deviation report documentation, competency checkoff on [SKILL_SET_PLACEHOLDER], questions and gaps review with supervisor [SUPERVISOR_PLACEHOLDER]. Include an end-of-orientation competency evaluation form outline. Write approximately 350–400 words with weekly milestone headers.

Write a professional internal memo communicating an update to an immunohistochemistry (IHC) protocol. Facility: [FACILITY_NAME]. TO: All Histology Lab Staff. FROM: [SUPERVISOR_NAME_PLACEHOLDER], [TITLE_PLACEHOLDER]. DATE: [EFFECTIVE_DATE_PLACEHOLDER]. RE: Update to [ANTIBODY_NAME] IHC Protocol — [PLATFORM_PLACEHOLDER].

What is changing: [WHAT_IS_CHANGING] (e.g., retrieval method for [ANTIBODY_NAME] changing from [OLD_METHOD] to [NEW_METHOD] based on validation study completed [DATE]; antibody clone changing from [OLD_CLONE] to [NEW_CLONE] — lot validation completed; primary antibody incubation time extended from [OLD_TIME] to [NEW_TIME] minutes to improve sensitivity on cell block and FFPE specimens; scoring criteria updated per [NEW_GUIDELINE_REFERENCE]).

Reason for change: [REASON] (e.g., CAP updated scoring guidelines for [ANTIBODY_NAME]; new clone shows superior sensitivity per in-house validation data; manufacturer protocol update).

Effective date: [EFFECTIVE_DATE]. Training required: [TRAINING_REQUIREMENT] (e.g., review attached updated SOP, complete supervised practice run with supervisor sign-off by [DATE]). Questions: contact [SUPERVISOR_PLACEHOLDER]. Write approximately 150–175 words in standard internal memo format.

Write a competency verification document for a histology staff member demonstrating competency in a special stain procedure. Staff member: [TECH_NAME], [CREDENTIAL]. Stain: [STAIN_NAME] (e.g., PAS, GMS, Trichrome, AFB Ziehl-Neelsen, Mucicarmine, Congo Red, Prussian Blue). Competency evaluation date: [EVAL_DATE]. Evaluator: [EVALUATOR_NAME_PLACEHOLDER].

Competency components assessed:
(1) Procedural knowledge — correctly identifies reagent sequence, dwell times, and critical temperature parameters from memory: Pass / Fail / Needs Review
(2) Reagent preparation (if applicable) — correctly prepares [REAGENT_PLACEHOLDER] per SOP: Pass / Fail / N/A
(3) Control tissue identification — correctly identifies appropriate positive and negative control tissues for [STAIN_NAME]: Pass / Fail
(4) Technical execution — produces QC-passing staining result on control tissue in supervised run: Pass / Fail / Needs additional practice
(5) QC documentation — correctly completes QC log entry per departmental requirements: Pass / Fail
(6) Troubleshooting — demonstrates understanding of 2 common failure modes for [STAIN_NAME] and appropriate corrective action: Pass / Fail

Overall competency determination: Competent / Not Yet Competent — re-evaluation scheduled: [REEVAL_DATE_PLACEHOLDER]. Write approximately 175–200 words in competency verification format.

Write a laboratory safety incident report for a formalin (formaldehyde) exposure event in the histopathology lab. Incident date/time: [INCIDENT_DATE] at [INCIDENT_TIME]. Reporting technician: [TECH_NAME], [CREDENTIAL]. Supervisor: [SUPERVISOR_NAME_PLACEHOLDER].

Exposure description: [EXPOSURE_DESCRIPTION] (e.g., formalin spill on bench surface during specimen container change — estimated volume [VOLUME_ML] mL; formalin splash to skin/eye during [ACTIVITY_PLACEHOLDER]; fume exposure from improperly sealed specimen container — duration [DURATION_PLACEHOLDER] minutes). PPE status at time of exposure: [PPE_STATUS] (e.g., gloves and lab coat worn but no eye protection — per OSHA 29 CFR 1910.1048, eye protection required when working with formalin).

Immediate action: [IMMEDIATE_ACTIONS] (e.g., area evacuated; fume hood activated; spill kit deployed per chemical hygiene plan; flush with water x 15 minutes [if skin/eye contact]; Employee Health notified at [NOTIFICATION_TIME]; air monitoring initiated per [MONITORING_PROTOCOL]).

OSHA Action Level: 0.5 ppm TWA; Permissible Exposure Limit: 0.75 ppm TWA; Short-Term Exposure Limit: 2 ppm. Medical evaluation status: [MEDICAL_EVAL_PLACEHOLDER]. Follow-up required: [FOLLOW_UP_PLACEHOLDER]. Write approximately 150–175 words in OSHA-consistent incident report format.

Write an orientation SOP for a new histotechnician's tissue grossing assistant responsibilities (pre-grossing specimen preparation and post-grossing cassette handling). Include: (1) Pre-grossing — specimen receipt verification (two patient identifiers vs. requisition), accessioning in LIS, specimen log entry, formalin volume adequacy check (minimum 10:1 formalin-to-tissue volume ratio per CAP guidelines), fixation time documentation, (2) Grossing support — submitting tissue sections into labeled cassettes per pathologist/prosector direction, cassette label verification (accession, part designation match requisition), (3) Post-grossing cassette handling — cassette count verification per gross description, cassette loading into tissue processor, processing protocol selection per specimen type ([SPECIMEN_TYPE_EXAMPLES_PLACEHOLDER] — overnight routine, extended, biopsy cycle, decalcification required), (4) Formalin handling — PPE requirements (gloves, lab coat, safety glasses minimum; chemical splash goggles for high-volume handling), disposal per institutional chemical waste protocol, (5) Documentation — complete gross log, flag any deviations for supervisor review immediately. Write approximately 350–400 words in structured SOP format with numbered sections.

Write a CAP inspection preparation summary for the histopathology laboratory. Lab section: Histology/Histotechnology. Prepared by: [TECH_NAME], [CREDENTIAL]. Inspection date: [INSPECTION_DATE_PLACEHOLDER]. Inspector type: [INSPECTOR_TYPE] (e.g., CAP peer review inspection, initial accreditation, scheduled triennial inspection).

Areas to cover in the summary:
(1) SOP currency — all histology SOPs reviewed and updated within the last [SOP_REVIEW_CYCLE] per CAP ANP.11890 requirement; dated and signed by lab director Dr. [DIRECTOR_NAME_PLACEHOLDER]. Outstanding SOPs requiring update: [SOP_LIST_PLACEHOLDER].
(2) QC documentation — H&E, special stain, and IHC QC logs complete for the [INSPECTION_PERIOD] review period; all control failures have corresponding corrective action documentation.
(3) Proficiency testing — current cycle PT results: [PT_STATUS_PLACEHOLDER]; all failures have documented corrective action responses.
(4) Personnel records — competency assessments current for all staff; annual reviews complete; new hire orientation records on file for [NEW_STAFF_PLACEHOLDER].
(5) Equipment maintenance — processor, microtomes, stainers, and cryostat maintenance logs current; temperature logs complete.
(6) Outstanding deficiencies from prior inspection: [PRIOR_DEFICIENCY_STATUS_PLACEHOLDER] (resolved / in progress — remediation documentation attached).

Write approximately 300–350 words in formal inspection preparation report format.

Write a formal corrective action plan response to a CAP inspection deficiency. Deficiency citation: [CAP_CHECKLIST_ITEM] (e.g., ANP.11840 — tissue processing QC records incomplete for [PERIOD]; ANP.22660 — immunohistochemistry controls not run with each batch; HST.05720 — section thickness outside validated range not documented; ANP.12025 — SOP for [STAIN_NAME] not reviewed within required cycle).

Deficiency description: [DEFICIENCY_DESCRIPTION_PLACEHOLDER].

Root cause: [ROOT_CAUSE] (e.g., QC log format did not include a required field — oversight during SOP revision; scheduling gap resulted in missed control run during [DATE_RANGE]; staff turnover created gap in SOP review cycle assignment).

Corrective action: [CORRECTIVE_ACTION] (immediate — [IMMEDIATE_ACTION_PLACEHOLDER]; systemic — [SYSTEMIC_FIX_PLACEHOLDER] e.g., added required field to QC log template; implemented redundant supervisor QC check; updated SOP review calendar with assigned staff for each cycle).

Timeline for completion: [COMPLETION_DATE_PLACEHOLDER]. Evidence of correction: [EVIDENCE_PLACEHOLDER] (e.g., updated QC log template attached; revised SOP dated [DATE] — lab director signed; staff retraining documentation). Lab director sign-off: Dr. [DIRECTOR_NAME_PLACEHOLDER]. Response deadline: [CAP_DEADLINE_PLACEHOLDER]. Write approximately 225–275 words in formal CAP deficiency response format.

Write a CLIA compliance readiness review summary for the histopathology section. Review conducted by: [TECH_NAME], [CREDENTIAL]. Review date: [REVIEW_DATE_PLACEHOLDER]. CLIA certificate type: [CLIA_CERT_TYPE] (e.g., accreditation via CAP, JCAHO deemed status).

Compliance areas reviewed:
(1) Personnel requirements — all testing personnel meet CLIA 42 CFR 493.1489 technical supervisor and testing personnel qualification standards for high-complexity testing; documentation on file.
(2) Procedure manual — all procedures in writing, readily available, reviewed within required cycle; includes all required elements per CLIA 42 CFR 493.1251.
(3) QC — control frequency meets or exceeds CLIA requirements for each stain category; QC failures documented with corrective action per 42 CFR 493.1282.
(4) Proficiency testing — enrolled in approved PT program for applicable analytes; PT performed by routine testing personnel; no PT referral violations.
(5) Test report — final reports contain all required elements per 42 CFR 493.1291.
(6) Patient test management — specimen labeling, accessioning, and retention meet requirements.

Outstanding items requiring remediation before inspection: [OUTSTANDING_ITEMS_PLACEHOLDER]. Write approximately 275–325 words in formal compliance review format.

Write a documentation record for annual SOP review in the histopathology lab. Protocol reviewed: [SOP_TITLE_PLACEHOLDER] (e.g., Tissue Processing — Routine Overnight Protocol; H&E Staining — Automated Leica ST5020; GMS Staining Procedure; IHC Protocol — [ANTIBODY_NAME]). SOP number: [SOP_NUMBER_PLACEHOLDER]. Review date: [REVIEW_DATE]. Reviewer: [TECH_NAME], [CREDENTIAL]. Lab director: Dr. [DIRECTOR_NAME_PLACEHOLDER].

Review determination (select one):
- No change required — protocol reviewed, verified current, practice unchanged. SOP approved as-is with updated review date.
- Minor update — [CHANGE_DESCRIPTION_PLACEHOLDER] (e.g., updated instrument model reference from [OLD_MODEL] to [NEW_MODEL]; updated reagent supplier reference; clarified step [STEP_NUMBER] language for precision — no change in procedure).
- Major revision — [REVISION_DESCRIPTION_PLACEHOLDER] (e.g., reagent sequence change based on updated manufacturer protocol; new retrieval method validated [DATE]; updated per CAP guideline revision [GUIDELINE_REFERENCE]).

If revised: changes initiated by [INITIATOR_PLACEHOLDER] based on [REASON]. Validation/verification data attached: [YES/NO_PLACEHOLDER]. Training completed by all affected staff by [TRAINING_DATE_PLACEHOLDER]. Prior SOP version: archived [DATE]. Lab director signature: Dr. [DIRECTOR_NAME_PLACEHOLDER]. Effective date: [EFFECTIVE_DATE_PLACEHOLDER]. Write approximately 175–200 words in SOP review record format.

Write a mock audit preparation checklist for a histopathology laboratory's special stains and immunohistochemistry section, structured around CAP ANP and IHC checklist requirements. Include verification items across:

Documentation: all special stain SOPs current and director-signed; IHC validation/verification records on file for each antibody performed; QC log completeness for the look-back period; corrective action documentation for all QC failures; reagent/lot change documentation; proficiency testing records and failure responses.

Controls: positive and negative tissue controls run with each patient batch (or per validated schedule); control tissue identity and appropriateness documented; external controls used where applicable.

Equipment: IHC platform preventive maintenance logs complete; temperature and pH records for retrieval buffers; annual calibration/verification documentation.

Personnel: competency assessments complete for all IHC-performing staff; training documentation for any protocol changes implemented in the prior 12 months; director qualifications documented.

CAP checklist items to spot-check: [CAP_ITEMS_PLACEHOLDER] (e.g., ANP.22660, ANP.22665, ANP.22680, IHC.20550, IHC.20900 — insert applicable item numbers for your lab's scope).

Format: two-column table with Checklist Item and Status (Complete / In Progress / Gap Identified). Write approximately 300–350 words with table format.

Write a TJC (The Joint Commission) readiness documentation summary for the histopathology laboratory's Environment of Care (EC) and Life Safety Code (LS) compliance. Prepared by: [TECH_NAME], [CREDENTIAL]. Review date: [REVIEW_DATE_PLACEHOLDER].

Areas covered:
(1) Chemical hygiene and hazardous materials (EC.02.02.01) — current SDS (Safety Data Sheets) accessible for all chemicals; formalin exposure monitoring current per OSHA 1910.1048; spill response kit stocked and staff trained; secondary containment in place for formalin.
(2) Fire and life safety (LS.02.01.35) — fire extinguisher inspection current; exit routes unobstructed; flammable reagent storage in approved flammable storage cabinets; xylene/alcohol quantities within NFPA 30 storage limits.
(3) Electrical safety — no daisy-chained power strips; equipment in good repair; no visible cord hazards.
(4) Biohazardous waste — waste containers labeled, covered, not overfilled; disposal records current.
(5) Personal protective equipment — PPE available and accessible at all workstations; staff observed using PPE appropriately.

Outstanding items for remediation: [OUTSTANDING_ITEMS_PLACEHOLDER]. Write approximately 275–325 words in EC/LS readiness format.

Create a structured self-study guide for the HT(ASCP) or HTL(ASCP) Board of Certification examination covering histochemical staining principles. Include: (1) H&E staining mechanism — hematoxylin as a basic dye binding to acidic nuclear chromatin (basophilia); eosin as an acidic dye binding to basic cytoplasmic and stromal proteins (eosinophilia); progressive vs. regressive staining method; (2) Connective tissue stains — Masson's Trichrome (collagen blue/green, muscle red/orange, nuclei dark), Verhoeff-Van Gieson (elastic fibers black, collagen red, muscle yellow); (3) Mucin stains — Alcian Blue pH 2.5 (acid mucins blue), PAS (neutral mucins magenta), Mucicarmine (epithelial mucin red); (4) Microorganism stains — GMS (fungi, Pneumocystis — black), Gram stain (G+ purple, G- red), Ziehl-Neelsen/acid-fast (mycobacteria red); (5) Pigment and mineral stains — Prussian Blue (hemosiderin/iron blue), Congo Red (amyloid — apple-green birefringence), Von Kossa (calcium black). Format: stain name, target structure, color result, and one clinical application per entry. Include a sample exam question with worked answer. Approximately 375–425 words in structured study guide format with table.

Write strong, results-oriented resume bullet points for a histotechnologist or histotechnician position. Role: [ROLE_TITLE] (e.g., Histotechnician, Histotechnologist, Senior Histotech, Histology Lab Supervisor). Facility type: [FACILITY_TYPE] (e.g., high-volume academic pathology lab, community hospital pathology department, reference histology lab, dermatopathology practice). Key responsibilities: [RESPONSIBILITIES] (e.g., tissue processing, embedding, microtomy, H&E and special stain batch processing, IHC runs, frozen section assistance, QC documentation, CAP accreditation compliance). Volume metrics (de-identified): [VOLUME_PLACEHOLDER] (e.g., processed [X] cassettes per shift, managed [X] special stain platforms). Format: strong action-verb bullets, 12–15 words each, quantified where possible. Generate 8–10 bullets. Avoid "responsible for." Open with action verbs: Processed, Performed, Executed, Maintained, Reduced, Trained, Achieved, Managed, Documented.

Write a professional cover letter for a senior histotechnologist or histology lab supervisor position. Applicant credential: [YOUR_CREDENTIAL] (e.g., HT(ASCP) with [X] years experience, HTL(ASCP), QIHC[ASCP]). Target role: [ROLE_TITLE] at [FACILITY_NAME_PLACEHOLDER]. Key experience: [EXPERIENCE_HIGHLIGHTS] (e.g., high-volume histology processing, IHC platform management, CAP accreditation experience, frozen section tech experience, new staff training and orientation, QC system management). Certifications: [CERTIFICATIONS_PLACEHOLDER] (e.g., HT(ASCP), HTL(ASCP), QIHC(ASCP), CLIA training certificate, CAP inspection training). Why this facility: [REASON_PLACEHOLDER]. Tone: confident, direct, professional. Approximately 275–300 words. Do not open with "I am writing to express my interest." Start with a strong sentence that leads with clinical value — something specific about what you bring to pathology lab accuracy, quality, and throughput. Standard cover letter format.

Generate 7 common histotechnician or histotechnologist job interview questions with detailed answer frameworks. Include: (1) Walk me through your tissue processing workflow from receipt to slide — what do you check at each step? (2) Describe a QC failure you identified and the corrective action you took. (3) How do you ensure section quality consistency when you are processing 80–100 cassettes per shift? (4) What is your experience with IHC platforms and what do you do when a control fails? (5) Tell me about a challenging tissue type you have worked with and how you adapted your technique. (6) How do you approach orienting a new histotech who has never used an automated tissue processor? (7) Why do you want to work at [FACILITY_TYPE_PLACEHOLDER]? For each question: provide a 100–130 word answer framework using the STAR method with specific histology terminology — processing protocols, stain names, QC procedures, accreditation references. Approximately 800–900 words total.

Write a 6-week self-study plan for the HT(ASCP) Board of Certification examination. Exam target: HT(ASCP) — ASCP Board of Certification. Exam date: [EXAM_DATE_PLACEHOLDER]. Current experience level: [EXPERIENCE_LEVEL] (e.g., completing histology technician program clinical practicum, 12 months laboratory experience, cross-training from cytology). Weak topic areas to prioritize: [WEAK_AREAS] (e.g., staining mechanisms and chemistry, tissue processing chemistry — dehydration, clearing, infiltration; decalcification methods; IHC principles; artifact recognition and correction; CLIA/CAP compliance requirements). Study resources available: [RESOURCES] (e.g., ASCP exam prep guide, Sheehan & Hrapchak "Theory and Practice of Histotechnology," departmental SOPs, online histology question banks). Study hours per week: [STUDY_HOURS]. Week-by-week schedule with daily topic assignments, self-quiz checkpoints at weeks 2 and 4, and a final review week strategy. Approximately 350–400 words.

Write a professional LinkedIn summary or bio for a certified histotechnologist or histotechnician. Credential: [CREDENTIAL] (e.g., HT(ASCP), HTL(ASCP), QIHC(ASCP)). Years of experience: [YEARS_EXPERIENCE]. Facility types: [FACILITY_TYPES] (e.g., academic pathology lab, community hospital histology, dermatopathology, reference lab). Key strengths: [KEY_STRENGTHS] (e.g., high-volume tissue processing, IHC platform operation and troubleshooting, CAP accreditation compliance, frozen section technique, special stain expertise, new staff training). Career direction: [CAREER_GOAL] (e.g., advancing to lead histotech or lab supervisor, pursuing HTL(ASCP) credential, transitioning to pathology assistant program, quality management). Tone: professional but personable — reads like a real person, not a job description. Approximately 175–200 words. First person. Do not start with "I am a histotechnologist." Lead with what you bring to diagnostic accuracy and laboratory quality.

Write a professional thank-you letter to send after a histology lab job interview. Interviewer: [INTERVIEWER_NAME_PLACEHOLDER], [TITLE_PLACEHOLDER] at [FACILITY_NAME_PLACEHOLDER]. Interview date: [INTERVIEW_DATE_PLACEHOLDER]. One specific topic that resonated during the interview: [MEMORABLE_TOPIC_PLACEHOLDER] (fill in after the actual interview — e.g., the lab's upcoming IHC platform transition, the team's CAP inspection preparation, the frozen section volume and complexity). Why you remain enthusiastic: [ENTHUSIASM_REASON_PLACEHOLDER]. What you specifically bring: [SPECIFIC_FIT_PLACEHOLDER] (e.g., your experience with the platform they are transitioning to, your CAP inspection participation history). Format: professional, warm, specific to the conversation. Approximately 150 words. Send within 24 hours. Do not write a generic "thank you for your time" — reference something specific that was discussed.

Write a 6-month professional development plan for a histotechnician or histotechnologist. Current role and experience level: [CURRENT_ROLE_AND_YEARS]. Career goal at 6 months: [SIX_MONTH_GOAL] (e.g., earn HT(ASCP) certification, advance to lead histotech, cross-train in IHC, begin prerequisites for pathologist assistant program, qualify for HTL(ASCP) credential by completing BS degree requirements). Month-by-month milestones: one per month for 6 months (e.g., Month 1: complete baseline HT exam practice assessment — identify top 3 weak content areas; Month 2: complete staining chemistry self-study module; Month 3: complete processing and embedding competency review; Month 4: first timed full-length practice exam; Month 5: IHC and special stain deep-dive, mock exam under timed conditions; Month 6: sit for HT(ASCP) exam or submit program application). Resources needed: [RESOURCES_PLACEHOLDER]. How to measure success: [SUCCESS_METRICS_PLACEHOLDER]. Write approximately 275–325 words with month-by-month milestone headers.